Related Experiment Video

Updated: Nov 16, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.2K

m6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma

Hongbo Wang1, Xiangxuan Zhao1, Zaiming Lu1

  • 1Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.

Frontiers in Genetics
|March 1, 2021
PubMed

Insights

Five N6-methyladenosine [m6A] regulatory factors are linked to lung adenocarcinoma patient survival. These factors offer prognostic value and highlight activated pathways in high-risk LUAD patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • N6-methyladenosine (m6A) is a prevalent mRNA modification in eukaryotes.
  • m6A plays crucial roles in mRNA metabolism, including splicing, stability, and translation.
  • m6A modification is implicated in tumor progression, affecting proliferation, migration, and invasion.

Purpose of the Study:

  • To identify m6A regulatory factors associated with overall survival (OS) in lung adenocarcinoma (LUAD).
  • To evaluate the prognostic value of these identified factors for LUAD patient outcomes.
  • To explore activated signaling pathways in high-risk LUAD patient groups.

Main Methods:

  • Identification of five key m6A regulatory factors: HNRNPA2B1, HNRNPC, KIAA1429/VIRMA, RBM15, and METTL3.
  • Analysis of the association between these factors and the overall survival (OS) of LUAD patients.
  • Investigation of signaling pathways activated in high-risk LUAD patient cohorts.

Main Results:

  • Five m6A regulatory factors (HNRNPA2B1, HNRNPC, KIAA1429/VIRMA, RBM15, METTL3) were found to be closely related to LUAD patient OS.
  • These factors demonstrated potential prognostic value for 1, 3, and 5-year survival outcomes in LUAD.
  • Activated signaling pathways in the high-risk group included cell cycle, DNA replication, RNA degradation, RNA polymerase, nucleotide excision repair, and basal transcription factors.

Conclusions:

  • The identified m6A regulatory factors serve as potential prognostic biomarkers for lung adenocarcinoma.
  • These findings contribute to understanding the role of m6A modification in LUAD pathogenesis.
  • Targeting these factors or related pathways may offer novel therapeutic strategies for LUAD.
Keywords:
N6-methylAdenosine (m6A)cancer biomarkerepitranscriptomicslung cancerprognosis

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.6K
Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.4K

Related Concept Videos

RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K